Screening jaundice in newborns with a smartphone app
Part of Genetic & congenital clinical trials.
This trial tests a smartphone app that checks for jaundice in newborns. The goal is to see if the app works well for on-the-spot screening, which could help parents and doctors detect jaundice early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a newborn, between 0 and 28 days old.
- Your baby is full-term (born at 37 weeks or later).
- Your baby does not need urgent medical care right now.
- Your baby has not recently had phototherapy (light treatment for jaundice).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a light-based device can measure bilirubin levels accurately without a blood test, by comparing it with the standard blood test. It looks at newborns of different skin colours to make sure the device works for everyone.
This study tests whether having families use a skin color chart at home helps spot jaundice early and supports better breastfeeding. If your newborn is healthy and full-term, you may be able to join and get extra guidance.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This trial tests a special hat-like glasses to protect babies' eyes during phototherapy (light treatment for jaundice). It is for healthy full-term newborns who are in a regular hospital room.
This study tests a device that measures jaundice level through the skin without needing a blood test. It is for newborns who need light therapy.
This study is looking at a new scoring system to help doctors quickly tell how severe jaundice is in newborns. The goal is to better decide when a baby needs stronger treatment like a blood exchange, so the right care can be given sooner.
Hear when a new Neonatal Jaundice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.